Triple
T2371049
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Rituxan |
E46089
|
entity |
| Predicate | hasBiosimilar |
P37220
|
FINISHED |
| Object |
Ruxience
Ruxience is a biosimilar monoclonal antibody to rituximab used in the treatment of certain cancers and autoimmune diseases.
|
E261831
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Ruxience | Statement: [Rituxan, hasBiosimilar, Ruxience]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Ruxience Context triple: [Rituxan, hasBiosimilar, Ruxience]
-
A.
REX
REX is a radio science experiment instrument aboard NASA's New Horizons spacecraft used to study the atmospheres and surfaces of planetary bodies through radio signal measurements.
-
B.
Vivanco
Vivanco is a Spanish-language surname of likely Iberian origin borne by various notable individuals.
-
C.
Xan
Xan is a short, informal diminutive of the given name Xander.
-
D.
Rosaliac
Rosaliac is a La Roche-Posay skincare line formulated to soothe, strengthen, and visibly reduce redness in sensitive, redness-prone skin.
-
E.
Arlanxeo
Arlanxeo is a global synthetic rubber company specializing in high-performance elastomer products for the automotive, construction, and industrial sectors.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Ruxience Triple: [Rituxan, hasBiosimilar, Ruxience]
Generated description
Ruxience is a biosimilar monoclonal antibody to rituximab used in the treatment of certain cancers and autoimmune diseases.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Ruxience Target entity description: Ruxience is a biosimilar monoclonal antibody to rituximab used in the treatment of certain cancers and autoimmune diseases.
-
A.
REX
REX is a radio science experiment instrument aboard NASA's New Horizons spacecraft used to study the atmospheres and surfaces of planetary bodies through radio signal measurements.
-
B.
Vivanco
Vivanco is a Spanish-language surname of likely Iberian origin borne by various notable individuals.
-
C.
Xan
Xan is a short, informal diminutive of the given name Xander.
-
D.
Rosaliac
Rosaliac is a La Roche-Posay skincare line formulated to soothe, strengthen, and visibly reduce redness in sensitive, redness-prone skin.
-
E.
Arlanxeo
Arlanxeo is a global synthetic rubber company specializing in high-performance elastomer products for the automotive, construction, and industrial sectors.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a88a145268819083e2736cb835c696 |
completed | March 4, 2026, 7:37 p.m. |
| NER | Named-entity recognition | batch_69abc76f5aec8190867d621e6849258c |
completed | March 7, 2026, 6:36 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69aea8a2b1448190b19179cf379993ee |
completed | March 9, 2026, 11:01 a.m. |
| NEDg | Description generation | batch_69aeac6b13ac81909042dddef15ec924 |
completed | March 9, 2026, 11:18 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69aead16b0a881909103e26053cfad84 |
completed | March 9, 2026, 11:20 a.m. |
Created at: March 4, 2026, 7:56 p.m.